2010 annual financial data
Iovance Biotherapeutics 2010 Operating margin
Direct answer
Operating margin was Not calculable.
Operating income was -815,000 USD and net income was -1,608,000 USD.
Operating cash flow was -620,805 USD.
Get free Iovance Biotherapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- Not available
- Operating income
- -815,000 USD
- Net income
- -1,608,000 USD
- Operating cash flow
- -620,805 USD